Jesper Haaning

Person

Birkerod, DK

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds suitable for treatment of haemophilia
- Patent number 9,125,890
- Issue date Sep 8, 2015
- Novo Nordisk A/S
- Gert Bolt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor VII or Factor VIIa Gla domain variants
- Patent number 8,987,202
- Issue date Mar 24, 2015
- Bayer HealthCare LLC
- Jesper Mortensen Haaning
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for therapeutic vaccination
- Patent number 7,820,633
- Issue date Oct 26, 2010
- BN Immunotherapeutics, Inc.
- Lucilla Steinaa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for therapeutic vaccination
- Patent number 7,807,441
- Issue date Oct 5, 2010
- BN Immunotherapeutics, Inc.
- Lucilla Steinaa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor V11 or factor V11A GLA domain variants
- Patent number 7,807,638
- Issue date Oct 5, 2010
- Bayer HealthCare LLC
- Jesper Mortensen Haaning
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FVII or FVIIa variants
- Patent number 7,771,996
- Issue date Aug 10, 2010
- Bayer HealthCare LLC
- Kim Vilbour Andersen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Factor VII or VIIa polypeptide variants
- Patent number 7,700,733
- Issue date Apr 20, 2010
- Bayer HealthCare LLC
- Jesper Mortensen Haaning
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for down-regulating osteoprotegerin ligand activity
- Patent number 6,645,500
- Issue date Nov 11, 2003
- M & E Biotech A/S
- Torben Halkier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Compounds Suitable for Treatment of Haemophilia
- Publication number 20160318991
- Publication date Nov 3, 2016
- Novo Nordisk A/S
- Gert Bolt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Suitable for Treatment of Haemophilia
- Publication number 20160207977
- Publication date Jul 21, 2016
- Novo Nordisk A/S
- Ole Hvilsted Olsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Composition Suitable for Treatment of Haemophilia
- Publication number 20160120954
- Publication date May 5, 2016
- Novo Nordisk A/S
- Gert Bolt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Suitable for Treatment of Haemophilia
- Publication number 20150080309
- Publication date Mar 19, 2015
- Nova Nordisk A/S
- Gert Bolt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Composition Suitable for Treatment of Haemophilia
- Publication number 20150045303
- Publication date Feb 12, 2015
- Novo Nordisk A/S
- Gert Bolt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS SUITABLE FOR TREATMENT OF HAEMOPHILIA
- Publication number 20140018297
- Publication date Jan 16, 2014
- Gert Bolt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FVII OR FVIIA VARIANTS
- Publication number 20100330669
- Publication date Dec 30, 2010
- Bayer Healthcare LLC
- Kim Vilbour Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RANK LIGAND-BINDING POLYPEPTIDES
- Publication number 20090017499
- Publication date Jan 15, 2009
- Maxygen Holdings Ltd.
- Jesper Mortensen Haaning
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FVII or FVIIa Gla domain variants
- Publication number 20070117756
- Publication date May 24, 2007
- MaXygen Holdings, Ltd
- Jesper Mortensen Haaning
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fvii or fviia variants
- Publication number 20070054366
- Publication date Mar 8, 2007
- MAXYGEN HOLDINGS LTD.
- Kim Vilbour Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Factor VII or VIIa Polypeptide Variants
- Publication number 20060276377
- Publication date Dec 7, 2006
- MaXygen Holdings, Ltd
- Jesper Mortensen Haaning
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Factor VII or VIIa Polypeptide Variants
- Publication number 20060270001
- Publication date Nov 30, 2006
- MaXygen Holdings, Ltd
- Jesper Mortensen Haaning
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Factor VII or VIIa Polypeptide Variants
- Publication number 20060270000
- Publication date Nov 30, 2006
- MaXygen Holdings, Ltd
- Jesper Mortensen Haaning
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Factor VII or VIIa Polypeptide Variants
- Publication number 20060270002
- Publication date Nov 30, 2006
- MaXygen Holdings, Ltd
- Jesper Mortensen Haaning
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FVII OR FVIIa GLA DOMAIN VARIANTS
- Publication number 20060252128
- Publication date Nov 9, 2006
- Maxygen Holdings Ltd.
- Jesper Mortensen Haaning
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FVII OR FVIIA GLA DOMAIN VARIANTS
- Publication number 20060240526
- Publication date Oct 26, 2006
- Maxygen Holdings Ltd.
- Jesper Mortensen Haaning
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FVII OR FVIIA GLA DOMAIN VARIANTS
- Publication number 20060241041
- Publication date Oct 26, 2006
- Maxygen Holdings Ltd.
- Jesper Mortensen Haaning
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fvii or fviia variants having increased clotting activity
- Publication number 20060166874
- Publication date Jul 27, 2006
- Jesper Mortensen Haaning
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Factor vii or viia polypeptide variants
- Publication number 20060111282
- Publication date May 25, 2006
- Maxygen Holdings Ltd.
- Jesper Mortensen Haaning
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FVII or FVIIa Gla domain variants
- Publication number 20050164932
- Publication date Jul 28, 2005
- MaXygen Holdings, Ltd
- Jesper Mortensen Haaning
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel methods for therapeutic vaccination
- Publication number 20040141958
- Publication date Jul 22, 2004
- M&E Biotech A/S
- Lucilla Steinaa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Rank ligand-binding polypeptides
- Publication number 20040132971
- Publication date Jul 8, 2004
- Jesper Mortensen Haaning
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method for down-regulating osteoprotegerin ligand activity
- Publication number 20040115199
- Publication date Jun 17, 2004
- M&E Biotech A/S
- Torben Halkier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jesper Haaning

Person

Patents Grantslast 30 patents

Compounds suitable for treatment of haemophilia

Factor VII or Factor VIIa Gla domain variants

Methods for therapeutic vaccination

Methods for therapeutic vaccination

Factor V11 or factor V11A GLA domain variants

FVII or FVIIa variants

Factor VII or VIIa polypeptide variants

Method for down-regulating osteoprotegerin ligand activity

Patents Applicationslast 30 patents

Compounds Suitable for Treatment of Haemophilia

Compounds Suitable for Treatment of Haemophilia

Pharmaceutical Composition Suitable for Treatment of Haemophilia

Compounds Suitable for Treatment of Haemophilia

Pharmaceutical Composition Suitable for Treatment of Haemophilia

COMPOUNDS SUITABLE FOR TREATMENT OF HAEMOPHILIA

FVII OR FVIIA VARIANTS

RANK LIGAND-BINDING POLYPEPTIDES

FVII or FVIIa Gla domain variants

Fvii or fviia variants

Factor VII or VIIa Polypeptide Variants

Factor VII or VIIa Polypeptide Variants

Factor VII or VIIa Polypeptide Variants

Factor VII or VIIa Polypeptide Variants

FVII OR FVIIa GLA DOMAIN VARIANTS

FVII OR FVIIA GLA DOMAIN VARIANTS

FVII OR FVIIA GLA DOMAIN VARIANTS

Fvii or fviia variants having increased clotting activity

Factor vii or viia polypeptide variants

FVII or FVIIa Gla domain variants

Novel methods for therapeutic vaccination

Rank ligand-binding polypeptides

Method for down-regulating osteoprotegerin ligand activity